Clozapine use in the first two years after first-episode psychosis in a real-world clinical sample.

Autor: Pechuán E; Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain., Toll A; Departament de Psiquiatria, Hospital Universitari Germans Trias i Pujol (HGTiP), Badalona (Barcelona), Spain; Institut de Recerca Germans Trias i Pujol (IGTP), Badalona (Barcelona), Spain; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Barcelona, Spain. Electronic address: albatollprivat@gmail.com., Bergé D; Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Barcelona, Spain; Fundació Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Legido T; Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain; Fundació Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Martínez-Sadurní L; Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain; Fundació Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Trabsa A; Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain; Fundació Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., De Iturbe G; Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain., Fernández SG; Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain., Jiménez-Fernández B; Departament de Psiquiatria, Hospital Universitari Germans Trias i Pujol (HGTiP), Badalona (Barcelona), Spain., Fernández A; Departament de Psiquiatria, Hospital Universitari Germans Trias i Pujol (HGTiP), Badalona (Barcelona), Spain; Institut de Recerca Germans Trias i Pujol (IGTP), Badalona (Barcelona), Spain; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Pérez-Solà V; Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Barcelona, Spain; Fundació Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Mané A; Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Barcelona, Spain; Fundació Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.

Publikováno v: Spanish journal of psychiatry and mental health [Span J Psychiatry Ment Health] 2024 Jun 20. Date of Electronic Publication: 2024 Jun 20.

Differential effect of cannabis in gray matter extracellular free-water in early psychosis subjects versus controls

Autor: Baquero, D. Bergé, Barrera-Conde, M., Cristeto, S., Vazquez, G., Trabsa, A., Martinez-Sadurni, L., Mané, A., Robledo, P.

Publikováno v: In Neuroscience Applied 2022 1 Supplement 2

Obstetric complications and clinical presentation in first episode of psychosis.

Autor: Verdolini N; Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain., Mezquida G; Barcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Clinical Institute of Neuroscience, University of Barcelona, CIBERSAM, IDIBAPS, Barcelona, Spain., Valli I; Child and Adolescent Psychiatry and Psychology Department, Hospital Clinic of Barcelona, Institute of Neurosciences, CIBERSAM, IDIBAPS, University of Barcelona, Barcelona, Spain., Garcia-Rizo C; Barcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Clinical Institute of Neuroscience, University of Barcelona, CIBERSAM, IDIBAPS, Barcelona, Spain., Cuesta M; Department of Psychiatry, Navarre Hospital Complex, IdiSNA, Navarre Institute for Health Research, Pamplona, Spain., Vieta E; Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain., Bioque M; Barcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Clinical Institute of Neuroscience, University of Barcelona, CIBERSAM, IDIBAPS, Barcelona, Spain., Lobo A; Department of Medicine and Psychiatry, Universidad de Zaragoza; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza; CIBERSAM, Madrid, Spain., González-Pinto A; Hospital Universitario de Alava, Servicio de Psiquiatría, BIOARABA, CIBERSAM, University of the Basque Country, Spain., Pina-Camacho L; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, CIBERSAM, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain., Corripio I; Department of Psychiatry, CIBERSAM, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Garriga M; Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain., Baeza I; Child and Adolescent Psychiatry and Psychology Department, Hospital Clinic of Barcelona, Institute of Neurosciences, CIBERSAM, IDIBAPS, University of Barcelona, Barcelona, Spain., Martínez-Sadurní L; Hospital del Mar Medical Research Institute (IMIM), Autonomous University of Barcelona, CIBERSAM, Barcelona, Spain., Bitanihirwe B; The University of Manchester Humanitarian and Conflict Response Institute, UK., Cannon M; Department of Psychiatry, RCSI University of Medicine and Health Science, Dublin, Ireland., Bernardo M; Barcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Clinical Institute of Neuroscience, University of Barcelona, CIBERSAM, IDIBAPS, Barcelona, Spain.

Publikováno v: Acta neuropsychiatrica [Acta Neuropsychiatr] 2023 Jun; Vol. 35 (3), pp. 156-164. Date of Electronic Publication: 2023 Mar 02.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids.

Autor: Barrera-Conde M; Integrative Pharmacology and Systems Neuroscience, Neuroscience Research Program, IMIM-Hospital del Mar Research Institute, Barcelona, Spain; Department of Medicine and Life Sciences, University Pompeu Fabra, Barcelona, Spain., Veza-Estévez E; Integrative Pharmacology and Systems Neuroscience, Neuroscience Research Program, IMIM-Hospital del Mar Research Institute, Barcelona, Spain., Gomis-Gonzalez M; Integrative Pharmacology and Systems Neuroscience, Neuroscience Research Program, IMIM-Hospital del Mar Research Institute, Barcelona, Spain., Garcia-Quintana J; Integrative Pharmacology and Systems Neuroscience, Neuroscience Research Program, IMIM-Hospital del Mar Research Institute, Barcelona, Spain., Trabsa A; Neuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Barcelona, Spain., Martínez-Sadurní L; Neuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Barcelona, Spain., Pujades M; Integrative Pharmacology and Systems Neuroscience, Neuroscience Research Program, IMIM-Hospital del Mar Research Institute, Barcelona, Spain., Perez V; Neuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Bellaterra, Spain; Centro de Investigación Biomédica en Red de Salud Mental G21. Instituto de Salud Carlos III, Madrid, Spain., de la Torre R; Integrative Pharmacology and Systems Neuroscience, Neuroscience Research Program, IMIM-Hospital del Mar Research Institute, Barcelona, Spain; Department of Medicine and Life Sciences, University Pompeu Fabra, Barcelona, Spain; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain., Bergé D; Neuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Bellaterra, Spain; Neuroimaging Group, Neuroscience Research Program, IMIM-Hospital del Mar Research Institute, Barcelona, Spain., Robledo P; Integrative Pharmacology and Systems Neuroscience, Neuroscience Research Program, IMIM-Hospital del Mar Research Institute, Barcelona, Spain; Department of Medicine and Life Sciences, University Pompeu Fabra, Barcelona, Spain. Electronic address: probledo@imim.es.

Publikováno v: Neurobiology of disease [Neurobiol Dis] 2023 Jan; Vol. 176, pp. 105942. Date of Electronic Publication: 2022 Dec 05.